Zurich Cantonal Bank
CMPX icon

Zurich Cantonal Bank’s Compass Therapeutics CMPX Stock Holding History

Zurich Cantonal Bank’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.2K Hold
43,914
– – ﹤0.01% 2414
2026
Q1 		$232K Buy
+43,914
New +$253K ﹤0.01% 2198
2023
Q4 		– Sell
-24,314
Closed -$47.9K – 2747
2023
Q3 		$47.9K Hold
24,314
– – ﹤0.01% 2609
2023
Q2 		$77.3K Buy
+24,314
New +$76.3K ﹤0.01% 2460

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Zurich Cantonal Bank's CMPX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Compass Therapeutics (CMPX) position steady in Q2 2026 at 43,914 shares worth $96.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2414.

Zurich Cantonal Bank first reported a position in CMPX in Q2 2023 and has held it in 4 quarters since. The position peaked at $232K in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Zurich Cantonal Bank held 43,914 shares of Compass Therapeutics worth $96.2K as of Q2 2026.
  • Zurich Cantonal Bank left its Compass Therapeutics share count unchanged in Q2 2026.
  • Compass Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2414 holding.
  • Zurich Cantonal Bank first reported a position in Compass Therapeutics in Q2 2023 and has held it in 4 quarters since.
  • Zurich Cantonal Bank's Compass Therapeutics position peaked at $232K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.